Markets:

Overview

News

Currencies

International

Treasuries

Hoth Therapeutics, Inc. - Common Stock (NQ:HOTH)

1.060 +0.020 (+1.92%)

Streaming Delayed Price Updated: 10:02 AM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hoth Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Why Hoth Therapeutics Shares Are Nosediving ↗

December 30, 2022

Hoth Therapeutics Inc (NASDAQ: HOTH) shares are trading lower by 21.22% to $8.44 Friday morning after the company announced a $10 million private placement priced at-the-market under Nasdaq rules.

Via Benzinga

US Stocks Open Lower; Dow Drops 250 Points ↗

December 30, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Friday.

Via Benzinga

Ardelyx To Rally 160%? Here Are 10 Other Price Target Changes For Friday ↗

December 30, 2022

Citigroup raised Ardelyx, Inc. (NASDAQ: ARDX) price target from $6 to $7. Citigroup analyst Yigal Nochomovitz maintained a Buy rating on the stock. Ardelyx shares rose 9.4% to $2.7685 on Friday.

Via Benzinga

Global Rheumatoid Arthritis Drugs Market Expected To Hit US$ 70 Billion By 2030

December 30, 2022

EQNX::TICKER_START (NASDAQ:SILO),(NASDAQ:BXRX),(NASDAQ:HOTH),(NASDAQ:KALA),(NASDAQ:NUWE) EQNX::TICKER_END

Via FinancialNewsMedia

FDA Signs Off Hoth Therapeutics' Trial Application For HT-001 For Skin Cancers ↗

December 29, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 30, 2022

Via Benzinga

Why Dermata Therapeutics Shares Are Trading Higher By Over 100%; Here Are 21 Stocks Moving Premarket ↗

December 30, 2022

Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 105% to $0.41 in pre-market trading after the company requested to withdraw its registration on Form S-1 and said it does not intend to...

Via Benzinga

Tesla, Apple, Ford, Southwest Airlines, Hoth Therapeutics: Why These Five Stocks Are Drawing Investors' Attention Today? ↗

December 29, 2022

Major Wall Street indices closed over 1% higher on Thursday after the much-awaited year-end rally materialized in the form of dip-buying. The Nasdaq Composite closed 2.59% higher while the S&P 500 rose...

Via Benzinga

EXCLUSIVE: The Benzinga Moneymaker Series, 5 Emerging Stocks For Investors To Watch ↗

December 29, 2022

Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. The rise of social media and retail traders gave way to countless methods to uncover new information....

Via Benzinga

Dow Rises Over 1%; Cal-Maine Foods Shares Plummet ↗

December 29, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing around 250 points on Thursday.

Via Benzinga

Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session ↗

December 29, 2022

Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 29, 2022

Via Benzinga

Nasdaq Jumps Over 250 Points; Crude Oil Down 1% ↗

December 29, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones climbing around 400 points on Thursday.

Via Benzinga

Dow, Nasdaq Up Triple Digits In Latest Last-Ditch Rally ↗

December 29, 2022

Stocks are attempting a last-minute rally before the year comes to a close, as investors react to higher-than-expected jobless claims data.

Via Talk Markets

Dow Surges 250 Points; Jobless Claims Rise To 225,000 ↗

December 29, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 28, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 21, 2022

Via Benzinga

Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session ↗

December 20, 2022

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who...

Via Benzinga

Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket ↗

December 20, 2022

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares rose 158% to $2.42 in pre-market trading after the company announced interim results from the ICESECRET study for the treatment of patients with small...

Via Benzinga

Why Is Hoth Therapeutics (HOTH) Stock Up 24% Today? ↗

October 31, 2022

Hoth Therapeutics (HOTH) stock is rising higher on Monday with heavy trading and positive results from a Phase 1 clinical trial of BioLexa.

Via InvestorPlace

Why Global Payments Shares Are Trading Lower By Around 8%? Here Are 41 Stocks Moving In Monday's Mid-Day Session ↗

October 31, 2022

Gainers 1847 Holdings LLC (NASDAQ: EFSH) shares surged 72.7% to $3.25 after the company reported it sees over $60 million in revenue and over $7 million in cash flow from operations in 2023 from its...

Via Benzinga

Nasdaq Down Over 100 Points; Chicago PMI Drops Further ↗

October 31, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Monday.

Via Benzinga

Hoth Therapeutics (NASDAQ: HOTH) Releases BioLexa Phase 1B Trial Results Showing Positive Results in Treating Mild to Moderate Atopic Dermatitis

October 31, 2022

Hoth Therapeutics, Inc. (NASDAQ: HOTH) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development

Via Spotlight Growth

Hoth Therapeutics' Atopic Dermatitis Candidate Shows Improvement In Severity, Shares Jump ↗

October 31, 2022

Hoth Therapeutics Inc (NASDAQ: HOTH) announced Phase 1b trial data for BioLexa in adult patients with mild-to-moderate atopic dermatitis.

Via Benzinga

What's Going On With Hoth Therapeutics Stock? ↗

October 31, 2022

Hoth Therapeutics Inc (NASDAQ: HOTH) shares are trading higher Monday after the company announced positive BioLexa Phase 1b clinical trial results.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 26, 2022

On Wednesday, 53 companies reached new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

October 28, 2022

During Friday, 125 stocks hit new 52-week lows.

Via Benzinga

Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday ↗

October 26, 2022

Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company.

Via Benzinga

Nasdaq Surges Over 200 Points; General Electric Posts Downbeat Earnings ↗

October 25, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

October 25, 2022

On Tuesday, 120 companies set new 52-week lows.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.